These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 20417416)

  • 21. Update on antiviral DNA vaccine research (1998-2000).
    Schultz J; Dollenmaier G; Mölling K
    Intervirology; 2000; 43(4-6):197-217. PubMed ID: 11251376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination and heterologous immunity: educating the immune system.
    Gil A; Kenney LL; Mishra R; Watkin LB; Aslan N; Selin LK
    Trans R Soc Trop Med Hyg; 2015 Jan; 109(1):62-9. PubMed ID: 25573110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006.
    Chang S; Ball R; Braun MM
    Vaccine; 2008 May; 26(19):2428-32. PubMed ID: 18406499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases.
    Klein SL
    Bioessays; 2012 Dec; 34(12):1050-9. PubMed ID: 23012250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetically Modified Rabies Virus Vector-Based Rift Valley Fever Virus Vaccine is Safe and Induces Efficacious Immune Responses in Mice.
    Zhang S; Hao M; Feng N; Jin H; Yan F; Chi H; Wang H; Han Q; Wang J; Wong G; Liu B; Wu J; Bi Y; Wang T; Sun W; Gao Y; Yang S; Zhao Y; Xia X
    Viruses; 2019 Oct; 11(10):. PubMed ID: 31597372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethics of vaccination programs.
    Schwartz JL; Caplan AL
    Curr Opin Virol; 2011 Oct; 1(4):263-7. PubMed ID: 22440783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.
    Choi JA; Goo J; Yang E; Jung DI; Lee S; Rho S; Jeong Y; Park YS; Park H; Moon YH; Park U; Seo SH; Lee H; Lee JM; Cho NH; Song M; Kim JO
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32967955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination of travelers: how far have we come and where are we going?
    Chen LH; Hill DR; Wilder-Smith A
    Expert Rev Vaccines; 2011 Nov; 10(11):1609-20. PubMed ID: 22043959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant viruses as vaccines against viral diseases.
    Souza AP; Haut L; Reyes-Sandoval A; Pinto AR
    Braz J Med Biol Res; 2005 Apr; 38(4):509-22. PubMed ID: 15962176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep.
    Bird BH; Maartens LH; Campbell S; Erasmus BJ; Erickson BR; Dodd KA; Spiropoulou CF; Cannon D; Drew CP; Knust B; McElroy AK; Khristova ML; Albariño CG; Nichol ST
    J Virol; 2011 Dec; 85(24):12901-9. PubMed ID: 21976656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Route of infectious bronchitis virus vaccination determines the type and magnitude of immune responses in table egg laying hens.
    Al-Rasheed M; Ball C; Ganapathy K
    Vet Res; 2021 Nov; 52(1):139. PubMed ID: 34772449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of supplemental chromium on antibody responses of newly arrived feeder calves to vaccines and ovalbumin.
    Chang GX; Mallard BA; Mowat DN; Gallo GF
    Can J Vet Res; 1996 Apr; 60(2):140-4. PubMed ID: 8785720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting of non-dominant antigens as a vaccine strategy to broaden T-cell responses during chronic viral infection.
    Holst PJ; Jensen BA; Ragonnaud E; Thomsen AR; Christensen JP
    PLoS One; 2015; 10(2):e0117242. PubMed ID: 25679375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic approach to vaccine complexity using an automaton model of the cellular and humoral immune system. I. Viral characteristics and polarized responses.
    Kohler B; Puzone R; Seiden PE; Celada F
    Vaccine; 2000 Nov; 19(7-8):862-76. PubMed ID: 11115710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perspectives on novel vaccine development.
    Wang YB; Wang LP; Li P
    Pol J Vet Sci; 2018 Sep; 21(3):643-649. PubMed ID: 30468351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current vaccination strategies].
    Dietz K
    Internist (Berl); 1992 Sep; 33(9):575-80. PubMed ID: 1399392
    [No Abstract]   [Full Text] [Related]  

  • 37. Human leukocyte antigen polymorphisms: variable humoral immune responses to viral vaccines.
    Ovsyannikova IG; Dhiman N; Jacobson RM; Poland GA
    Expert Rev Vaccines; 2006 Feb; 5(1):33-43. PubMed ID: 16451106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection induced by a glycoprotein E-deleted bovine herpesvirus type 1 marker strain used either as an inactivated or live attenuated vaccine in cattle.
    Romera SA; Puntel M; Quattrocchi V; Del Médico Zajac P; Zamorano P; Blanco Viera J; Carrillo C; Chowdhury S; Borca MV; Sadir AM
    BMC Vet Res; 2014 Jan; 10():8. PubMed ID: 24401205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic vaccines against infectious diseases.
    Moingeon P; Almond J; de Wilde M
    Curr Opin Microbiol; 2003 Oct; 6(5):462-71. PubMed ID: 14572538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of reproductive performance of primiparous dairy cattle following revaccination with either modified-live or killed multivalent viral vaccines in early lactation.
    Walz PH; Montgomery T; Passler T; Riddell KP; Braden TD; Zhang Y; Galik PK; Zuidhof S
    J Dairy Sci; 2015 Dec; 98(12):8753-63. PubMed ID: 26454300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.